{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T18:06:59Z","timestamp":1770314819713,"version":"3.49.0"},"reference-count":39,"publisher":"The Ewha Medical Journal, Ewha Womans University College of Medicine","issue":"1","license":[{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":["e-emj.org"],"crossmark-restriction":true},"short-container-title":["Ewha Med J"],"published-print":{"date-parts":[[2026,1,31]]},"abstract":"<jats:p>Purpose: Human papillomavirus is the dominant etiological factor underlying atypical cervical squamous epithelial cell abnormalities and cervical carcinoma. Currently, only a limited number of drugs targeting specific biomarkers in cervical cancer are available. This study aimed to assess the expression of estrogen receptor (ER), human epidermal growth factor receptor 2 (HER2), and the Ki-67 proliferative index (Ki-67) in p16-positive cervical squamous premalignant and malignant lesions, which may help clarify the potential role of targeted therapies in cervical cancer.Methods: In p16-positive, histologically proven premalignant and malignant cervical lesions, ER, HER2, and Ki-67 expression were evaluated according to predefined criteria.Results: p16 showed strong nuclear and cytoplasmic positivity in 54 of 56 cases. Patchy nuclear positivity was mainly observed in low-grade squamous intraepithelial lesion (LSIL) cases (2\/56). Ki-67 demonstrated a variable proliferative index ranging from 5% to 95% across all cases, with higher indices predominantly observed in squamous cell carcinomas (SCC). ER positivity in LSIL, high-grade squamous intraepithelial lesion, and SCC was 100% (2\/2), 66.7% (10\/15), and 46.15% (18\/39), respectively. HER2 expression was predominantly negative, observed in 78.6% (44\/56) of cases, equivocal in 17.8% (10\/56), and positive in 3.6% (2\/56). Both HER2-positive cases were SCC. ER and HER2 interpretations were analyzed and were not significantly correlated with clinical or pathological parameters.Conclusion: ER positivity decreased with progression of cervical squamous lesions, and HER2 expression was rare in cervical squamous neoplasia. No statistically significant correlation was identified between ER or HER2 expression and clinicopathological parameters. The findings of the current study may help fill gaps in the existing literature and provide essential foundational knowledge for optimizing emerging therapeutic strategies, including ER- and HER2-related therapies.<\/jats:p>","DOI":"10.12771\/emj.2025.01088","type":"journal-article","created":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T04:50:06Z","timestamp":1769748606000},"page":"e5","update-policy":"https:\/\/doi.org\/10.12771\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Immunohistochemical expression of Ki-67, estrogen receptor, and human epidermal growth factor receptor 2 in p16-positive premalignant and malignant cervical squamous lesions: associations with clinicopathological parameters"],"prefix":"10.12771","volume":"49","author":[{"given":"Ashwini","family":"Pitambra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0725-0494","authenticated-orcid":true,"given":"Jitendra Singh","family":"Nigam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9652-0179","authenticated-orcid":true,"given":"Immanuel","family":"Pradeep","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6255-8286","authenticated-orcid":true,"given":"Ashutosh","family":"Rath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9956-2246","authenticated-orcid":true,"given":"Seetu","family":"Palo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5970-6935","authenticated-orcid":true,"given":"Naina","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4998","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834"},{"key":"ref2","first-page":"336","volume-title":"","author":"Herrington","year":"2020"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.12659\/MSM.892807"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2010.03.005"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.7860\/JCDR\/2017\/26583.10547"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0257976"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/PGP.0000000000000853"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.4103\/ijpm.ijpm_656_21"},{"key":"ref9","first-page":"2979","volume-title":"P16 and Ki-67 expression improves the diagnostic accuracy of cervical lesions but not predict persistent high risk human papillomavirus infection with CIN1","author":"Zhong","year":"2015"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.anndiagpath.2019.151443"},{"key":"ref11","first-page":"3007","volume-title":"Different expression of p16INK4a and p14ARF in cervical and lung cancers","author":"Li","year":"2013"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexmp.2013.06.011"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexmp.2015.04.004"},{"key":"ref14","first-page":"781","volume-title":"Utility of Ki-67 and p53 in distinguishing cervical intraepithelial neoplasia 3 from squamous cell carcinoma of the cervix","author":"Tan","year":"2008"},{"key":"ref15","first-page":"191","volume-title":"Oncoprotein c-erbB-2 in squamous cell carcinoma of the uterine cervix and evaluation of its significance in response of disease to treatment","author":"Bhadauria","year":"2001"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.4103\/jcrt.jcrt_43_21"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3892\/or.2011.1256"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-93358-x"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.31557\/APJCP.2020.21.11.3221"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2010.02.014"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/S1607-551X(09)70350-X"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.2298\/mpns1408202n"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1097\/01.pgp.0000092137.88121.8d"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1006\/gyno.1999.5429"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.14670\/HH-22.587"},{"key":"ref26","first-page":"91","volume-title":"HER-2 expression in uterine cervix carcinogenesis","author":"Protrka","year":"2007"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.4103\/0377-4929.56127"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1111\/j.1447-0756.2010.01227.x"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.3233\/CBM-160060"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1002\/(sici)1097-0142(19980501)82:9<1709::aid-cncr18>3.0.co;2-8"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1097\/00004347-199407000-00007"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1111\/j.1048-891X.2004.14529.x"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/0090-8258(89)90082-6"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0463.2009.02531.x"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1007\/BF01625727"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.2741\/1949"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2017.05.068"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19960801)78:3<433::AID-CNCR9>3.0.CO;2-K"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19950515)75:10<2523::aid-cncr2820751019>3.0.co;2-l"}],"container-title":["Ewha Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/e-emj.org\/upload\/pdf\/emj-2025-01088.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/e-emj.org\/journal\/view.php?doi=10.12771\/emj.2025.01088","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/e-emj.org\/upload\/pdf\/emj-2025-01088.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T06:10:25Z","timestamp":1770271825000},"score":1,"resource":{"primary":{"URL":"http:\/\/e-emj.org\/journal\/view.php?doi=10.12771\/emj.2025.01088"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,31]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"URL":"https:\/\/doi.org\/10.12771\/emj.2025.01088","relation":{},"ISSN":["2234-3180","2234-2591"],"issn-type":[{"value":"2234-3180","type":"print"},{"value":"2234-2591","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,31]]},"assertion":[{"value":"2025-12-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-19","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-28","order":2,"name":"published","label":"Published online","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-31","order":3,"name":"published","label":"Print publication","group":{"name":"publication_history","label":"Publication History"}}]}}